Macfarlane Group PLC (MACF)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 81.40 |
|---|---|
| 52-week range | 59.80 – 85.40 |
| Return, 1 month / 3 months | +3.0% / +19.4% |
| Return, 1 year / 3 years | +21.3% / −9.2% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 32.7% |
| Worst drawdown (1 year) | -19.6% |
| Average daily value traded | 22.92M GBX |
| Dividend yield | 4.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Macfarlane Group is a packaging company based in Glasgow, Scotland. It supplies businesses with packaging materials and distributes a wide range of protective and transit packaging products. The company also designs and makes protective packaging, serving customers across sectors such as retail, electronics, food and manufacturing. Its work covers the supply of everyday packaging items alongside custom protective solutions for companies that need to ship and store goods safely.
On this site Macfarlane Group PLC appears as a stock on the London Exchange (UK), code MACF, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Macfarlane Group PLC (MACF) trades on the London Exchange in UK. It last closed at GBX 81.40 on 22 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 229 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.3% and over the last three months it rose 19.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.3% | ||
| From 52-week high | -4.1% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 19.4% | ||
| 6-month return | 25.0% | ||
| 12-month return, skipping the last month | 17.7% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.6% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 22.92M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +3.0% |
| 3 months | +19.4% |
| 6 months | +25.0% |
| 1 year | +21.3% |
| 3 years | −9.2% |
| 5 years | −26.9% |
Signals
| 50-day / 200-day average | 78.39 / 68.83 |
|---|---|
| Golden / death cross (60 days) | Golden, 56 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | GBP 0.0096 |
| 14 May 2026 | GBP 0.0270 |
| 11 Sep 2025 | GBP 0.0096 |
| 15 May 2025 | GBP 0.0270 |
| 12 Sep 2024 | GBP 0.0096 |
| 9 May 2024 | GBP 0.0265 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.